Cargando…

Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from México

The rapid growth of diabetes in middle-income countries is generating disparities in global health. In this context we conducted a study to quantify the health disparities from the economic burden of diabetes in México. Evaluative research based on a longitudinal design, using cost methodology by in...

Descripción completa

Detalles Bibliográficos
Autores principales: Arredondo, Armando, Reyes, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709919/
https://www.ncbi.nlm.nih.gov/pubmed/23874629
http://dx.doi.org/10.1371/journal.pone.0068443
_version_ 1782276820981252096
author Arredondo, Armando
Reyes, Gabriela
author_facet Arredondo, Armando
Reyes, Gabriela
author_sort Arredondo, Armando
collection PubMed
description The rapid growth of diabetes in middle-income countries is generating disparities in global health. In this context we conducted a study to quantify the health disparities from the economic burden of diabetes in México. Evaluative research based on a longitudinal design, using cost methodology by instrumentation. For the estimation of epidemiological changes during the 2010–2012 period, several probabilistic models were developed using the Box-Jenkins technique. The financial requirements were obtained from expected case management costs by disease and the application of an econometric adjustment factor to control the effects of inflation. Comparing the economic impact in 2010 versus 2012 (p<0.05), there was a 33% increase in financial requirements. The total amount for diabetes in 2011 (US dollars) was $7.7 billion. It includes $3.4 billion in direct costs and $4.3 in indirect costs. The total direct costs were $.4 billion to the Ministry of Health (SSA), serving the uninsured population; $1.2 to the institutions serving the insured population (Mexican Institute for Social Security–IMSS-, and Institute for Social Security and Services for State Workers-ISSSTE-); $1.8 to users; and $.1 to Private Health Insurance (PHI). If the risk factors and the different health care models remain as they currently are in the analyzed institutions, health disparities in terms of financial implications will have the greatest impact on users’ pockets. In middle-income countries, health disparities generated by the economic burden of diabetes is one of the main reasons for catastrophic health expenditure. Health disparities generated by the economic burden of diabetes suggests the need to design and review the current organization of health systems and the relevance of moving from biomedical models and curative health care to preventive and socio-medical models to meet expected challenges from diseases like diabetes in middle-income countries.
format Online
Article
Text
id pubmed-3709919
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37099192013-07-19 Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from México Arredondo, Armando Reyes, Gabriela PLoS One Research Article The rapid growth of diabetes in middle-income countries is generating disparities in global health. In this context we conducted a study to quantify the health disparities from the economic burden of diabetes in México. Evaluative research based on a longitudinal design, using cost methodology by instrumentation. For the estimation of epidemiological changes during the 2010–2012 period, several probabilistic models were developed using the Box-Jenkins technique. The financial requirements were obtained from expected case management costs by disease and the application of an econometric adjustment factor to control the effects of inflation. Comparing the economic impact in 2010 versus 2012 (p<0.05), there was a 33% increase in financial requirements. The total amount for diabetes in 2011 (US dollars) was $7.7 billion. It includes $3.4 billion in direct costs and $4.3 in indirect costs. The total direct costs were $.4 billion to the Ministry of Health (SSA), serving the uninsured population; $1.2 to the institutions serving the insured population (Mexican Institute for Social Security–IMSS-, and Institute for Social Security and Services for State Workers-ISSSTE-); $1.8 to users; and $.1 to Private Health Insurance (PHI). If the risk factors and the different health care models remain as they currently are in the analyzed institutions, health disparities in terms of financial implications will have the greatest impact on users’ pockets. In middle-income countries, health disparities generated by the economic burden of diabetes is one of the main reasons for catastrophic health expenditure. Health disparities generated by the economic burden of diabetes suggests the need to design and review the current organization of health systems and the relevance of moving from biomedical models and curative health care to preventive and socio-medical models to meet expected challenges from diseases like diabetes in middle-income countries. Public Library of Science 2013-07-12 /pmc/articles/PMC3709919/ /pubmed/23874629 http://dx.doi.org/10.1371/journal.pone.0068443 Text en © 2013 Arredondo, Reyes http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Arredondo, Armando
Reyes, Gabriela
Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from México
title Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from México
title_full Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from México
title_fullStr Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from México
title_full_unstemmed Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from México
title_short Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from México
title_sort health disparities from economic burden of diabetes in middle-income countries: evidence from méxico
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709919/
https://www.ncbi.nlm.nih.gov/pubmed/23874629
http://dx.doi.org/10.1371/journal.pone.0068443
work_keys_str_mv AT arredondoarmando healthdisparitiesfromeconomicburdenofdiabetesinmiddleincomecountriesevidencefrommexico
AT reyesgabriela healthdisparitiesfromeconomicburdenofdiabetesinmiddleincomecountriesevidencefrommexico